CC(=O)NNc1nc(C)c(C(=O)/C=C/c2cccc([N+](=O)[O-])c2)s1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?